Karolina Okła
7PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Mar 11, 2023
Clinical Relevance of Mortalin in Ovarian Cancer Patients.Alicja Rajtak, Arkadiusz Czerwonka, Michael Pitter
|Jun 27, 2020
Correction to: Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1.Karolina Okła, Alicja Rajtak, Arkadiusz Czerwonka
|Jun 04, 2020
Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1.Karolina Okła, Alicja Rajtak, Arkadiusz Czerwonka
|Oct 02, 2019
Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties.Anna Wawruszak, Ewelina Gumbarewicz, Estera Okon
|Jul 31, 2019
Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity-An Isobolographic Analysis.Anna Wawruszak, Jarogniew J Luszczki, Joanna Kalafut
|Jan 10, 2019
Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms.Geert van Weelden, Marcin Bobiński, Karolina Okła
Pageof 2
Frequent Collaborators
2 joint publications
Anna Wawruszak
2 joint publications
Adolfo Rivero-Muller
1 joint publications
Andrea Romano
1 joint publications
Johanna M A Pijnenborg
1 joint publications
Ewelina Gumbarewicz
1 joint publications
Estera Okon
1 joint publications
Witold Jeleniewicz
1 joint publications
Jakub Czapinski
1 joint publications
Marta Halasa
1 joint publications
Jolanta Smok-Kalwat
